SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

DUATTI, Adriano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.406
AS - Asia 6.583
EU - Europa 4.640
SA - Sud America 1.313
AF - Africa 117
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 8
Totale 26.087
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.125
SG - Singapore 2.711
CN - Cina 1.973
BR - Brasile 1.126
DE - Germania 877
UA - Ucraina 834
IT - Italia 748
HK - Hong Kong 615
GB - Regno Unito 567
TR - Turchia 439
PL - Polonia 373
VN - Vietnam 354
FI - Finlandia 346
SE - Svezia 323
RU - Federazione Russa 196
MX - Messico 135
CA - Canada 117
IN - India 110
FR - Francia 91
ID - Indonesia 73
AR - Argentina 60
ZA - Sudafrica 60
BD - Bangladesh 52
NL - Olanda 50
BE - Belgio 45
JP - Giappone 44
ES - Italia 42
IQ - Iraq 34
AT - Austria 29
EC - Ecuador 27
VE - Venezuela 26
IR - Iran 24
UZ - Uzbekistan 24
CZ - Repubblica Ceca 23
CH - Svizzera 21
LT - Lituania 20
CO - Colombia 19
AU - Australia 18
PK - Pakistan 18
PY - Paraguay 18
MA - Marocco 17
CL - Cile 14
BG - Bulgaria 13
SA - Arabia Saudita 12
TW - Taiwan 12
KE - Kenya 11
AE - Emirati Arabi Uniti 10
UY - Uruguay 10
EG - Egitto 9
KR - Corea 9
RO - Romania 9
AZ - Azerbaigian 7
BO - Bolivia 6
EU - Europa 6
HU - Ungheria 6
IL - Israele 6
LB - Libano 6
LV - Lettonia 6
MY - Malesia 6
PA - Panama 6
DZ - Algeria 5
HN - Honduras 5
JO - Giordania 5
OM - Oman 5
GR - Grecia 4
IE - Irlanda 4
JM - Giamaica 4
KG - Kirghizistan 4
NP - Nepal 4
SY - Repubblica araba siriana 4
CR - Costa Rica 3
GA - Gabon 3
GY - Guiana 3
MN - Mongolia 3
PE - Perù 3
PH - Filippine 3
PS - Palestinian Territory 3
BN - Brunei Darussalam 2
BY - Bielorussia 2
CG - Congo 2
CI - Costa d'Avorio 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GT - Guatemala 2
KZ - Kazakistan 2
MK - Macedonia 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
KH - Cambogia 1
KW - Kuwait 1
LI - Liechtenstein 1
Totale 26.071
Salva come PNG Salva come JPEG
Città #
Singapore 1.596
Woodbridge 1.166
Fairfield 1.163
Ashburn 1.151
Houston 909
Jacksonville 844
Chandler 760
Ann Arbor 721
Santa Clara 644
Hong Kong 612
Beijing 544
Wilmington 502
Seattle 463
Warsaw 364
Cambridge 348
Nanjing 264
Izmir 256
Munich 237
Los Angeles 219
Princeton 195
Ferrara 194
Addison 186
New York 161
Dallas 130
Milan 128
The Dalles 126
São Paulo 125
San Diego 113
Helsinki 112
Ho Chi Minh City 109
Boardman 101
Falkenstein 96
Shenyang 94
Mexico City 91
Nanchang 80
Shanghai 75
Hefei 71
Hanoi 70
Tianjin 68
Council Bluffs 66
Turku 63
Dearborn 60
San Mateo 60
Falls Church 59
London 58
Dong Ket 57
Hebei 57
Buffalo 53
Changsha 53
San Jose 48
Brooklyn 46
Chicago 45
Redwood City 43
Stockholm 43
Tokyo 43
Jakarta 41
Bremen 40
Brussels 38
Jiaxing 38
Rio de Janeiro 37
Chennai 36
Denver 36
Moscow 35
Orem 35
Montreal 34
Johannesburg 33
Toronto 33
Boston 32
Nuremberg 32
Poplar 31
Amsterdam 30
Belo Horizonte 30
San Francisco 29
Auburn Hills 28
Guangzhou 28
Phoenix 28
Atlanta 27
Jinan 27
Kunming 27
Ningbo 27
Brasília 26
Frankfurt am Main 26
Zhengzhou 25
Bologna 24
Norwalk 24
Tashkent 23
Curitiba 22
Washington 19
Des Moines 18
Mumbai 18
Padova 18
Querétaro 18
Rome 18
Vienna 18
Ankara 17
Augusta 17
Legnaro 17
Taizhou 16
Guarulhos 15
Mountain View 15
Totale 17.148
Salva come PNG Salva come JPEG
Nome #
In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals 469
14 MeV neutrons for 99Mo/99mTc production: Experiments, simulations and perspectives 357
Preclinical SPECT-CT imaging studies with cyclotron produced Tc-99m 295
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 244
E-learning as a tool to harmonize education and good quality assurance system in radiopharmacy 242
LARAMED: A Laboratory for Radioisotopes of Medical Interest 240
A solvent-extraction module for cyclotron production of high-purity technetium-99m 229
A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma 221
YAP-(S)PET small animal scanner: Quantitative results 217
An alternative approach to the preparation of (188)Re radiopharmaceuticals from generator-produced [(188)ReO(4)]:(-) efficient synthesis of (188)Re(V)-meso-2,3-dimercaptosuccinic acid 209
A new solvent-extraction module for a local routine production of technetium-99m by medical cyclotrons 208
Remotely controlled solvent extraction of high purity Tc-99m produced by conventional medical cyclotrons 206
Technetium(V)-nitrido complexes of dithiocarbazic acid derivatives. Reactivity of (Tc=N)2+ core towards Schiff bases derived from S-methyl dithiocarbazate. Crystal structures of (S-methyl-3-(2-hydroxyphenyl-methylene) dithiocarbazato) nitrido (triphenylphosphine) Technetium(V) and bis(S-methyl-3- isopropylidene dithiocarbazato) nitrido Technetium(V). 206
Formation of the Tc≡N multiple bond from the reaction of ammonium pertechnetate with S-methyl dithiocarbazate and its application to the preparation of technetium-99m radiopharmaceuticals 191
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptors 189
Automated preparation of Re-188 lipiodol for the treatment of hepatocellular carcinoma 188
Synthesis and Structure of an Amino Sugar-Schiff Base Complex of Technetium(V) Containing Salicylaldehyde in an Unusual Coordination Mode 187
A novel approach to the high-specific-activity labeling of small peptides with the technetium-99m fragment [Tc-99m(N) (PXP)](2+) (PXP = diphosphine ligand) 187
Synthesis of hybrid distamycin-cysteine labeled with 99mTc: a model for a novel class of cancer imaging agents 185
Communicating across the boundaries 185
Development of an Automatic Separation/Extraction Module for the Accelerator 99mTc Production from 100Mo-Enriched Molybdenum Metal Targets 182
Tc(IV)Cl4(PPh3)2 and Tc(III)Cl3(CH3CN)(PPh3)2 as precursors of trans dioxo technetium(V) complexes with chelating amines and tetraazamacrocycles 180
Geometrically controlled selective formation of nitrido technetium(V) asymmetrical heterocomplexes with bidentate ligands 180
STRUCTURE OF TRANS-TRICHLOROBIS[DIETHYL(PHENYL)PHOSPHINE]HYDROXORHENIUM(IV) 177
Whole-Body Biodistribution and Radiation Dosimetry of the New Cardiac Tracer 99mTc-N-DBODC 177
A small animal hybrid PET-SPECT scanner: First in-vivo results. 176
A Study on the Gamma-Ray Background of the Images Obtained Using Accelerator- Produced 99mTc 175
THE STRUCTURE OF TRANS-DIBROMOOXO(N-PHENYLSALICYLIDENEAMINATO)(TRIPHENYLPHOSPHINE)RHENIUM (V), FORM-II (TRICLINIC), [REBR2(C13H10NO)O(P(C6H5)3)] 173
Labeling of Fatty Acid Ligands with the Strong Electrophilic Metal Fragment [99mTc(N)(PNP)]2+ (PNP=Diphosphane Ligand) 173
First evaluation in humans of the new myocardial perfusion imaging agent 99mTcN-dbodc: safety, biodistribution and dosimetry assessment 172
Design and synthesis of a redox-active Tc-99m radiopharmaceutical with ferrocenedithiocarboxylate [FcCS = Fe(C5H4CS2)(C5H5)-] 171
Radiofarmaci 170
First Accelerator-Based 99mTc GBq Production Levels and in-vivo Imaging Tests for APOTEMA Experiment 170
Association of Co(sep)3+ ions with S2O32- ions: Spectrophotometric, circular dichroism and solubility measurements 169
Photochemical synthesis and reaction of d6 metallocenes—tetracyanoethylene charge-transfer complexes 167
Synthesis, properties and X-ray crystal structure of Schiff base organo-imido complexes of rhenium(V) 166
Erratum: A kit formulation for the preparation of 188Re- lipiodol: Preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma (Nuclear Medicine Communication (2004) 25 (691-699)) 166
The emerging role of copper-64 radiopharmaceuticals as cancer theranostics 166
Isolation and Crystal Structure of a Technetium(V) Nitrido Complex Containing a Coordinated Transient State of N-(2-Aminoethyl)carbamic Acid 165
The chemistry of heteroallyl derivatives of technetium. Reactivity of [TcNCl2(PPh3)2] and [Tc(CO) 3Cl(PPh3)] with thiazetidine ligands, crystal structures of [Tc(CO)2(PPh3)2{PhN=C(OEt)S}] and [TcN(Cl)(PPh3)-{PhN=C(OEt)S}] 165
Synthesis of a novel class of nitrido Tc-99m radiopharmaceuticals with phosphino-thiol ligands showing transient heart uptake 164
Extraction techniques of 99mTc from 100Mo Metal Target 164
Synthesis and characterization of technetium-(IV) and -(III) complexes with bidentate Schiff bases. X-ray molecular structure of chloro(dimethylphenylphosphine)bis(N-phenylsalicylideneiminato)technetium(III) 163
Chemistry of the strong electrophilic metal fragment [99Tc(N)(PXP)]2+ (PXP = diphosphine ligand). A novel tool for the selective labeling of small molecules 162
Synthesis, reactivity and X-ray crystal structures of mixed thiazolato- or carboxylato-carbonyl(phosphine)-rhenium(I) complexes 162
Development of new 99mTc-labeled bisphosphonates for bone scintigraphy 162
Mixed tridentate π-donor and monodentate π -acceptor ligands as chelating systems for rhenium-188 and technetium-99m nitrido radiopharmaceuticals 161
Synthesis and X-ray crystal structure of the mixed organoimido, organoamine rhe-nium(V) complex [ReCl3(NC6H4Me-p)(NH2C6H4Me-p)PPh3] 159
Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies 159
The chemistry of heteroallene and heteroallyl derivatives of rhenium. Part 1. Reactiv-ity of mixed carbonyl(formamido)(phosphine)rhenium(I) complexes with RNCS (R = Ph or p-MeC6H4) and PhNCO. Crystal structure of the thiazetidine rhenium(I) com-plex [Re(CO)2(PPh3)2PhN=C(OEt)-S] 158
Synthesis and characterization of paramagnetic schiff base complexes of rhenium(IV) 156
RHENIUM(V) COMPLEXES WITH VINYL AMIDES 156
Crystal structure of trans-dicarbonylbis (dimethylphenylphoshine)(N-phenylsalicyl ideneaminato) rhenium(I) and mer-trichloro (dimethylphenylphosphine)(N-phenylsalicyl ideneaminato) rhenium(IV). Comparison of Re(I), Re(III), Re(IV) and Re(V) complexes with salicylideneaminato ligand and reaction mechanism. 155
Complexes of Tc(V) and Tc(III) with tridentate Schiff bases derived from S-Methyl dithiocarbazate. Crystal structures of chloro-[S-methyl-3-(2-hydroxy-1-naphtyl methylene) dithiocarbazato(2-)]oxotechnetium(V) and dichloro[S-methyl-3-(2-hydroxybenzilidene) dithiocarbazato(1)]bis (triphenylphosphine) technetium(III). 153
The crucial role of the diphosphine heteroatom X in the stereochemistry and stabilization of the substitution-inert [M(N)(PXP)](2+) metal fragments (M = Tc, Re; PXP = diphosphine ligand) 153
Radioisotopic purity and imaging properties of cyclotron-produced 99mTc using direct100Mo(p,2n) reaction 153
Influence of the Generator in-Growth Time on the Final Radiochemical Purity and Stability of Radiopharmaceuticals 152
Molecular imaging with endogenous and exogenous ligands: the instance of antibodies, peptides, iodide and cupric ions 152
Synthesis and x-ray crystal structure of the mixed organoimido, organoamine rhenium(V) complex ReCl3(NC6H4Me-p)(NH2C6H4Me-p)PPh3] 151
Clearance of technetium 99m N-NOET in normal, ischemic-reperfused, and membrane-disrupted myocardium 151
Chemistry and Bifunctional Chelating Agents for Binding Lu-177 151
Technetium(V)-nitrido complexes of dithiocarbazic acid derivatives. Reactivity of [Tc≡N]2+ core towards Schiff bases derived from S-methyl dithiocarbazate. Crystal structures of [S-methyl 3-(2-hydroxyphenylmethylene)dithiocarbazato]nitrido(triphenylphos-phine)technetium(V) and bis(S-methyl 3-isopropylidenedithiocarbazato)nitridotechnetium(V) 150
A remotely controlled module for an in-hospital routine production of Tc-99m by medical cyclotrons 149
Safety profile, biodistribution and dosimetry of the new myocardial perfusion imaging agent [99mTc]N.DBODC: first evaluation in Human. 148
Technetium-99m nitrido radiopharmaceuticals with unprecedented biological properties 147
A new efficient method for the preparation of 99mTc-radiopharmaceuticals containing the TcN multiple bond 146
PREPARATION AND CHARACTERIZATION OF MIXED AMIDO, CARBOXYLATO OR THIAZOLATO CARBONYL(PHOSPHINE)TECHNETIUM(I) COMPLEXES 146
Progress using Tc-99m radiopharmaceuticals for measuring high capacity sites and low density sites 146
Esophageal substitute using the Sparks prosthesis. Experimental study 145
POLAROGRAPHIC AND SPECTROPHOTOMETRIC INVESTIGATION OF THE REDUCTION AND DEPROTONATION OF (1,3,6,8,10,13,16,19-OCTA-AZABICYCLO-[6,6,6]-ICOSANE)COBALT(III) ION, CO(SEP)3+, IN THE PRESENCE OF DIFFERENT ANIONS 144
A Comparison of Separation and Purification Strategies for 51/52Mn cyclotron production 144
Reactivity of rhenium(I) pseudo-allyl complexes with heterocumulenes. Part 2. Inser-tion reactions. Crystal structures of the thiazolyl-thioureido and -dithiocarbamato complexes [Re(CO)2(PPh3)2SC(NPh)NMe(C3H2NS)] ·CH2Cl2 and [Re(CO)2(PPh3)2S2CNMe(C3H2NS)]·CH2Cl2 (C3H2NS = thiazol-2-yl) 143
Synthesis and characterization of nitrido Tc(V) and Re(V) complexes with ferrocenedithiocarboxylate {FcCS(2)=[Fe(C5H4CS2)(C5H5)](-)} 143
Synthesis of Technetium(V)-Nitrido Complexes with Chelating Amines: A Novel Class of Monocationic, Octahedral Complexes Containing the [Tc≡N]2+ Core. Crystal Structures of [TcN(en)2Cl]+ (en = Ethylenediamine) and [TcN(tad)Cl]+ (tad = 1,5,8,12-T etraazadodecane) 142
Bis(dithiocarbamato) nitrido technetium-99m radiopharmaceuticals: A class of neutral myocardial imaging agents 141
Reactions of the Technetium(I) Carbonyl Complexes [Tc(PMe2Ph)3(CO)2Cl] and [Tc(PPh3)2(CO)3Cl] toward Pseudoallyl Ligands Such as Triazenido, Formamidinato, and Acetamidinato. Crystal Structures of [Tc(PMe2Ph)2(CO)2(p-CH3C6H4N-N-NC6H4CH3-p)] and [Tc(PMe2Ph)2(CO)2(C6H5N-C(CH3)-NC6H5)] 141
Technetium and rhenium heterocomplexes containing the diphenylphosphinoferrocenyl fragment 141
Technetium(V) nitrido complexes with tetra-azamacrocycles: monocationic and neu-tral octahedral complexes containing the [Tc≡N]2+ core. Crystal structure of [TcN(L1)(H2O]·2H2O (H2L1 = 1,4,8,11-tetra-azacyclotetradecane-5,7-dione) 141
Crystal structures of trans-dicarbonylbis(dimethylphenylphosphine)(N-phenylsalicyl-ideneaminato)rhenium(I) and mer-trichloro(dimethylphenylphosphine)(N-phenyl-salicylideneaminato)rhenium(IV). Comparison of ReI, ReIII, ReIV, and ReV complexes with salicylideneaminato ligand and reaction mechanisms 140
Asymmetrical nitrido Tc-99m heterocomplexes: A class of cardiac agents with unprecedented imaging properties. 140
Mixed schiff base, carbonyl(phosphine)rhenium(I) complexes 139
Synthesis and biologic evaluation of monocationic asymmetric 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties 139
REDOX PROPERTIES OF A SERIES OF PSEUDOALLYL RHENIUM(I) COMPLEXES 138
The chemistry of heteroallene and heteroallyl derivatives of rhenium. Part 2. Reactiv-ity of [ReO(OR)Cl2(PPh3)2] (R = Me or Et) with RNCS ( R = Ph or p-MeC6H4). Crystal structure of the thiazetidine rhenium(V) complex [ReOCl2(PPh3) p-MeC6H4N=C(OEt)-S] 138
Reactivity of Schiff base rhenium(V) complexes with dimethylphenylphosphine 138
Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules 138
Labeling and biodistribution studies of Tc-99m radiopharmaceuticals with (o-hydroxyphenyl)diphenylphosphine 137
Technetium complexes and radiopharmaceuticals with scorpionate ligands 137
Rhenium(V) and Technetium(V) Nitrido Complexes with Mixed 2 Tridentate pigreco-Donor and Monodentate pigreco-Acceptor Ligands 136
PEGylated N-methyl-S-methyl dithiocarbazate as a new reagent for the high-yield preparation of nitrido Tc-99m and Re-188 radiopharmaceuticals 135
A class of asymmetrical nitrido Tc-99m heterocomplexes as heart imaging agents with improved biological properties 135
Advances in radiopharmaceuticals for cardiac imaging: 99mTcN-NOET 134
Is PET always an advantage versus planar and SPECT imaging? 134
In vivo imaging of oligonucleotides with nuclear tomography 133
Synthesis, solution-state and solid-state structural characterization of monocationic nitrido heterocomplexes [M(N)(DTC(PNP)](+) (M=Tc-99, Re; DTC = dithiocarbamate; PNP = heterodiphosphane) 133
Nonisotopic substitution: Is fluorine a replacement for hydrogen? 132
Incorporation of a glucose moiety in a technetium-99m nitrido compound 131
BIODISTRIBUTION IN MAN OF BIS [(N-ETHYL, N-ETHOXY) DITHIOCARBAMATE] NITRIDO TECHNETIUM-(V), A PROMISING NEW TRACER FOR MYOCARDIAL PERFUSION IMAGING 130
188W/188Re generator system and its therapeutic applicacions 129
Reactivity of 2-(2-hydroxyphenyl)benzothiazoline with the oxotetrahalometalate(V) complexes [MOX4]- (M = technetium, rhenium; X = Cl, Br). Synthesis and characterization of new oxo-M(V) complexes containing 2-(2-hydroxyphenyl)benzothiazole. Crystal structure of tetraphenylarsonium oxotrichloro[2-(2-hydroxyphenyl)benzothiazolato]technetate(V) 129
Totale 16.824
Salva come PNG Salva come JPEG
Categoria #
all - tutte 124.627
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 10.739
Totale 135.366
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.584 0 0 0 0 0 233 75 326 86 338 363 163
2021/20222.175 79 200 169 95 141 75 90 122 81 158 287 678
2022/20231.758 211 123 44 220 250 273 102 148 189 22 125 51
2023/2024968 91 113 81 39 63 104 71 64 19 28 29 266
2024/20254.825 137 94 332 148 510 312 246 358 724 609 909 446
2025/20266.515 1.129 432 916 1.600 1.771 667 0 0 0 0 0 0
Totale 26.388